Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company’s singular mission is to improve and prolong the lives of patients suffering from this disease. Launched in 2016 after years of research supported by Stanford’s SPARK program, Eidos is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.
View Top Employees from Eidos Therapeutics| Website | http://eidostx.com |
| Ticker | EIDX |
| Revenue | $12.7 million |
| Employees | 53 (51 on RocketReach) |
| Founded | 2016 |
| Address | 101 Montgomery St, San Francisco, California, US |
| Phone | (650) 391-9740 |
| Technologies |
JavaScript,
HTML,
PHP
+46 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Biopharma, Healthcare, Health Care, Science and Engineering, Pharmaceutical |
| Web Rank | 7 Million |
| Keywords | Eidos Therapeutics, Eidos, Neil Kumar, Eidx, Neil Kumar Bridgebio |
| Competitors | Annexon Biosciences, Minerva Neurosciences, Otonomy, Inc, Spruce Biosciences, VTV |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 541712 Companies, NAICS Code 5417 Companies |
Looking for a particular Eidos Therapeutics employee's phone or email?
Eidos Therapeutics Questions
The Eidos Therapeutics annual revenue was $12.7 million in 2024.
Leonid Katz is the Senior Vice President, Clinical Development of Eidos Therapeutics.
51 people are employed at Eidos Therapeutics.
Eidos Therapeutics is based in San Francisco, California.
The NAICS codes for Eidos Therapeutics are [54171, 54, 541711, 541, 541712, 5417].
The SIC codes for Eidos Therapeutics are [87, 873].
Top Eidos Therapeutics Employees
-
View
Stuart Heminway
Senior Vice President, Regulatory Affairs, BridgeBio Cardiorenal at Eidos Therapeutics
California, United States21 -
54
-
ViewLeonid Katz
Senior Vice President, Clinical Development at Eidos Therapeutics
California, United States35+ -
View
Janet Hsu
Vice President, Quality and Compliance at Eidos Therapeutics
California, United States25+ -
11
-
55+
-
ViewMark McGovern
Senior Director Clinical Operations at Eidos Therapeutics
California, United States5+5+ -
33
-
ViewRebecca Vanlandingham
Senior Director, Clinical Development at Eidos Therapeutics
Philadelphia, Pennsylvania, United States31 -
View
Olga Vlaskina
Director of Administration and Operations at Eidos Therapeutics
San Francisco, CA, US42
Related Companies
